This page shows the latest Sialanar news and features for those working in and with pharma, biotech and healthcare.
The CHMP reversed an earlier negative opinion on Proveca's Sialanar (glycopyrronium bromide) as a treatment for severe drooling in children and adolescents with neurological disorders, backing it under a paediatric
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...